[back] Medical Charities    http://www.chadd.org

[You can see the marketing benefits of shills] Ciba spends millions of dollars to sell parent groups and doctors on the idea of using Ritalin. Ciba helps to support the parent group, CH.A.D.D., and organized psychiatry.  The U.S. Department of Education and the National Institute of Mental Health (NIMH) push Ritalin as vigorously as the manufacturer of the drug, often in even more glowing terms than the drug company could get away with legally. Vital Information About Ritalin, Attention Deficit-Hyperactivity Disorder and the Politics Behind the ADHD/Ritalin Movement Summarized from Talking Back to Ritalin by Peter R. Breggin, M.D.

Jon Rappoport ( http://home.earthlink.net/~alto/     http://www.jonrappoport.com/) reviews the Merrow Report (featured on P), which reveals that Ciba-Geigy funded CHADD (Children with Attention Deficit Disorder) with $818,000, and that the U.S. Education also funded CHADD with $750,000 to produce a video (Facing the Challenge of ADD) which promoted Ritalin. The CHADD video was circulated throughout the U.S. Educational system. The CHADD video devoted only 20 seconds to Ritalin's adverse effects. It included interviews of parents who were satisfied with the effects of Ritalin on their children, yet, amazingly, all of these interviewed parents were CHADD board members. http://www3.bcity.com/harpub/

About 20 percent of the organization's budget in some years reportedly was underwritten by Ciba-Geigy (now Novartis), the maker of Ritalin. ("ADD - a Dubious Diagnosis?" PBS and the Merrow Report. [cited Dec. 20, 1995] <http://www.add-adhd.org/ritalin_CHADD_A.D.D.html>)
 CHADD was reported to have received from drug companies more than $1 million in grants and services. The Drug Enforcement Administration said, "The relationship between Ciba-Geigy and CHADD raises serious concerns about CHADD's motive in proselytizing the use of Ritalin." (DEA, "Methylphenidate (a background paper)," October 1995, p.4.)
 CHADD was said to have received about $30,000 from Novartis and ten percent of its income overall from the drug industry. (Phone call, John Heavener, CHADD, to CSPI/M. Jacobson; May 27, 1999.)
 "CHADD received $748,000 from Ciba/Novartis in the period 1991 to 1994 alone." (Law suit No. CV 1839 E (CGA); U.S. District Court, Southern District of California; Vess et al vs. Ciba-Geirgy et al.; 9/13/00)